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Abstract 
Bronchiolitis obliterans (BO) is an uncommon and severe sequela of chronic obstructive lung disease in children that 
results from an insult to the lower respiratory tract. Few prognostic factors achieved worldwide acknowledgment. 
In the present study, we retrospectively collected the children with respiratory adenoviral infection and identified 
the predictive factors of BO. In the period between Jan 2011 and December 2014, the consecutive in‑hospital acute 
respiratory infection children with positive result for adenovirus were enrolled into the present study. High resolu‑
tion computerized tomography and clinical symptoms were utilized as the diagnostic technique for BO. Multivariate 
analysis using a Logistic proportional hazards model was used to test for independent predictors of BO. A total of 544 
children were included with 14 (2.57 %) patients developed BO. Compared with children without BO, BO children 
presented higher LDH (523.5 vs. 348 IU/ml, p = 0.033), lower blood lymphocyte count (2.23 × 109/L vs. 3.24 × 109/L, 
p = 0.025) and higher incidence of hypoxemia (78.6 vs. 20.8 %, p = 0.000). They presented relatively persistent fever 
(15.5 vs. 7 days, p = 0.000) and needed longer treatment in hospital (19.5 vs. 7 days, p = 0.000). Concerning treatment, 
they were given more intravenous γ‑globulin (85.7 vs. 36.8 %, p = 0.000), glucocorticoids (78.6 vs. 24.3 %, p = 0.000) 
and mechanical ventilation (35.7 vs. 5.5 %, p = 0.001). Multiple analyses determined that hypoxemia was the only 
independent predictor for BO. The present study identified hypoxemia as the independent predictive factor of BO in 
adenoviral infected children, which was a novel and sensitive predictor for BO.
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Background
Bronchiolitis obliterans (BO) is an uncommon and severe 
sequela of chronic obstructive lung disease in children 
that results from certain insult to the lower respiratory 
tract. It is featured by tachypnoea, increased anteropos-
terior chest diameter, crackles, wheezing, and hypoxae-
mia for at least 30  days after the initial insult. Luminal 
obstruction with inflammation, granulation tissue, fibro-
sis, obliteration of the small airways and bronchiecta-
sis are the pathological characteristics (Li et  al. 2014; 
Champs et al. 2011; Xie et al. 2014; Bosa et al. 2008; Mos-
quera et al. 2014). Due to its poor prognosis and shortage 
of effective remedy, identification of predictive factors for 
BO became one of hottest topic in this field. However, 
few prognostic factors achieved worldwide acknowledg-
ment (Murtagh et al. 2009; Colom and Teper 2009; Yalcin 
et al. 2003; Khalifah et al. 2004). The latent causes might 
be the heterogenicity of this disease.
BO was a heterogeneous syndrome due to multi-
ple causes. The reported causes were indicated as acute 
rejection (El-Gamel et  al. 1999), lymphocytic bronchi-
tis (Husain et  al. 1999), cytomegalovirus pneumonitis 
(Heng et  al. 1998), adenoviral infection (Murtagh et  al. 
2009), single lung transplant (Hadjiliadis et  al. 2002), 
anti-human leukocyte antigen antibody development 
(Palmer et al. 2002), and et al. (Champs et al. 2011). The 
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predictors for BO in various backgrounds shall be diver-
gent widely due to different latent mechanisms. Thus 
prognostic analysis of BO shall be based on a single 
cause. Adenoviral infection was identified as the major 
cause for BO in children (Champs et  al. 2011; Murtagh 
et al. 2009; Khalifah et al. 2004). Thus, it is imperative to 
investigate the predictors for BO following respiratory 
adenoviral infection in children.
In our Women and Children’s Medical Center, a 1400 
bed tertiary children’s hospital located in Southern China 
with a service population of around 20 million people, we 
routinely test adenovirus in nasopharyngeal swabs by RT-
PCR assay or using serum IgM for in-hospital children 
with acute respiratory infection (ARI) since Jan 2011. In 
the present study, we retrospectively collected the chil-
dren with respiratory adenoviral infection and identified 
the predictive factors of BO.
Methods
Patients
In the period between Jan 2011 and December 2014, 
the consecutive in-hospital ARI children with positive 
result for adenovirus in nasopharyngeal swabs by RT-
PCR assay or serum IgM/IgG were enrolled into the pre-
sent study. Diagnosis and classification of ARI followed 
standard WHO algorithm for ARI. Briefly, children with 
cough, difficult breathing, or both were diagnosed ARI 
and screened for fast breathing. Children were classi-
fied as Table  1 (WHO 1991; Hazir et  al. 2011). Patients 
with one of following conditions were excluded from 
this study: patients presented congenital heart disease, 
congenital pulmonary dysplasia, immunodeficiency dis-
ease, malignances, severe organ dysfunction, had recently 
been pyrexial for 7  days before admission (temperature 
under the axillary is at or over 37.2  °C, had exhibited 
clinical evidence of active infection in other organs, had 
received corticosteroids within 1 week before admission 
for any reason and those with substantial missing data. 
The study was approved by the ethical committee of the 
Guangzhou Medical University, as well as the Guangzhou 
Women and Children’s Medical Center Hospital; writ-
ten informed consent was obtained from the patients’ 
parents.
Diagnosis of adenovirus infection
PCRs with DNA targets utilized 10  μl purified nucleic 
acid from Qiagen Quantitect Probe PCR kit (Qia-
gen, Crawley, UK). Thermal cycling conditions were as 
described previously, except for removal of the 50 °C hold 
for reverse transcription, and the enzyme activation hold 
at 95  °C was extended to fifteen minutes for the Qiagen 
Quantitect Probe PCR kit. All assays were performed in 
a Lightcycler 480 real-time PCR machine (Roche Diag-
nostics, Burgess Hill, UK). The Primers were forward 
“GCC ACG GTG GGG TTT CTA AAC TT”, reverse 
“GCC CCA GTG GTC TTA CAT GCA CAT C” and the 
sequence of the probe was “TGC ACC AGA CCC GGG 
CTC AGG TAC TCC GA” (Bezerra et  al. 2011). Serum 
adenovirus IgM/IgG were tested using diagnostic ELISA 
kit (IMMUNOLAB GmbH, Kassel).
Identification of BO
High resolution computerized tomography (HRCT) was 
utilized as the diagnostic technique for BO. It was con-
ducted when children presented tachypnoea, increased 
anteroposterior chest diameter, crackles, wheezing or 
hypoxaemia for at least 30 days after the initial of acute 
respiratory infection. The chest HRCT was performed 
during quiet breathing and evaluated by 2 blinded radi-
ologists. BO was defined on the presence of bronchiecta-
sis and/or a mosaic pattern. Mosaic pattern was defined 
as segmental orlobular areas of hypoattenuation that are 
associated with narrowing of the caliber of the pulmo-
nary vessels.
Data collection and follow up
Data as follows were included: gender, age, history of 
breast-feeding, premature birth, number of siblings, 
extention of infection (no pneumonia, pneumonia), and 
blood tests before treatment such as blood neutrophil 
count, blood lymphocyte count, alanine aminotrans-
ferase (ALT), aspartate aminotransferase (AST), creati-
nine kinase (CK), CK-MB, lactate dehydrogenase (LDH), 
and C-reactive protein (CRP), as well as parameters 
identified after admission including hypoxemia, myco-
plasma co-infection, bacterial co-infection, sepsis, usage 
Table 1 World Health Organization classification of  acute 






<50 (infants 2–11 months)
<40 (children 12–59 months)
No lower chest indrawing
Nonsevere pneumonia Respiratory rate (breaths/minute)
>50 (infants 2–11 months)
<40 (children 12–59 months)
No lower chest indrawing
Severe pneumonia Lower chest indrawing with or with‑
out rapid breathing
Very severe disease Unable to drink, convulsions, abnor‑
mally sleepy or difficult waking, 
stridor in calm child or clinically 
severe malnutrition
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of γ-globulin intravenously, use of antibiotics, use of glu-
cocorticoids, mechanical ventilation, length of fever and 
length of hospital stay.
We conducted a routine follow-up from admission 
to 1 month after delivery and recorded the following in 
detail: symptoms, concomitant medications and adverse 
reactions. All the children were followed up regularly, 
either at the clinic or by telephone.
Statistical analysis
The Kolmogorov–Smirnov test was used to evaluate the 
normality of distribution. Data were reported as median 
and range when distribution was not normal. Statistical 
differences in clinical characteristics between the 2 groups 
were compared using the t test, the Mann–Whitney test, 
and Fisher’s exact test. Group comparison tests were per-
formed using the Wilcoxon rank-sum test. Multivariate 
analysis using a Logistic proportional hazards model was 
used to test for independent significance by backward 
elimination of insignificant baseline characteristics and 
explanatory variables. For all tests, a p value  <  0.05 was 
considered statistically significant, and all p values quoted 
are 2-sided. Statistical analyses were performed using 
SPSS v. 20.0 (SPSS Inc., Chicago, IL, USA).
Results
Patient characteristics of children with or without BO 
following respiratory adenoviral infection
A total of 544 children (398 boys and 146 girls) met the 
eligibility criteria and were available for analysis. Among 
the 544 children, 456 children were diagnosed through 
PCR and 56 were by serum IgM with the rest 32 diag-
nosed by both methods. In the serology only group, sero-
conversion were confirmed in 47/56 (83.9  %) patients. 
The children had a median age of 23  months (range 
1–144 months). 14 (2.57 %) patients developed BO who 
were all diagnosed pneumonia at admission. Compared 
with children without BO, BO children presented higher 
LDH (523.5 vs. 348 IU/ml, p = 0.033), lower blood lym-
phocyte count (2.23 × 109/L vs. 3.24 × 109/L, p = 0.025) 
and higher incidence of hypoxemia (78.6 vs. 20.8  %, 
p  =  0.000). They presented relatively persistent fever 
(15.5 vs. 7 days, p = 0.000) and needed longer treatment 
in hospital (19.5 vs. 7 days, p = 0.000). Concerning treat-
ment, they were given more intravenous γ-globulin (85.7 
vs. 36.8  %, p =  0.000), glucocorticoids (78.6 vs. 24.3  %, 
p  =  0.000) and mechanical ventilation (35.7 vs. 5.5  %, 
p = 0.001) (Table 2).
Predictors of BO following respiratory adenoviral infection 
in children
Univariate analysis by Logistic regression revealed that 
length of hospital stay (p  =  0.000, HR 1.086, 95  % CI 
1.046–1.127), length of fever (p = 0.003, HR 1.062, 95 % 
CI 1.020–1.106), use of glucocorticoids (p  =  0.000, HR 
11.398, 95  % CI 3.131–41.486), mechanical ventilation 
(p = 0.000, HR 9.598, 95 % CI 3.022–30.480), hypoxemia 
(p =  0.000, HR 14.000, 95  % CI 3.839–51.050) and use 
of intravenous γ-globulin (p  =  0.002, HR 10.308, 95  % 
CI 2.283–46.535) were indicated as prognostic factors. 
Then, multiple analysis by Logistic regression using above 
parameters determined that hypoxemia was the only 
independent predictor for BO (p = 0.030, HR 5.046, 95 % 
CI 1.170–21.765) (Table 3). Then, patients with or with-
out hypoxemia were compared concerning the incidence 
Table 2 Characteristics of  children with  or without  bron-
chiolitis obliterans after respiratory adenoviral infection
BO bronchiolitis obliterans, ALT alanine aminotransferase, AST aspartate 
aminotransferase, CK creatinine kinase, LDH lactate dehydrogenase, CRP 
C-reactive protein
Characteristics Non-BO (n = 530) BO (n = 14) p
Gender 0.127
 Male 385 (72.6 %) 13 (92.9 %)
 Female 145 (27.4 %) 1 (7.1 %)
Age (months) 23.5 (1–144) 15.5 (6–72) 0.339
History of breast‑
feeding
305 (57.5 %) 9 (64.3 %) 0.818
Premature birth 34(6.4 %) 1 (7.1 %) 0.610
Number of siblings 0 (0–3) 1 (0–2) 0.096
Diagnosis 0.014
 No pneumonia 150 (28.3 %) 0 (0.0 %)
 Pneumonia 380 (71.7 %) 14 (100.0 %)
 Hypoxemia 110 (20.8 %) 11 (78.6 %) 0.000
CRP 14.92 (0.00–264.74) 26.25 (0.51–116.20) 0.155
Blood neutrophil  
count (×109/l)
5.49 (0.54–32.8) 4.46 (2.19–14.44) 0.767
Blood lymphocyte 
count (×109/l)
3.24 (0.36–35.29) 2.23 (0.83–6.77) 0.025
ALT (IU/ml) 18 (3–372) 16 (7–112) 0.405
AST (IU/ml) 41 (15–1400) 40.5 (29–391) 0.495
CK (IU/ml) 88.5 (11–5413) 91 (17–1038) 0.941
CK–MB (IU/ml) 25 (1–436) 24 (13–169) 0.959
LDH (IU/ml) 348 (14–10983) 523.5 (254–1945) 0.033
Mycoplasma  
co‑infection
143 (27.0 %) 4 (28.6) 0.999
Bacterial co‑infection 46 (8.7 %) 0 (0.0 %) 0.621
Sepsis 9 (1.7 %) 0 (0.0 %) 0.999
Use of γ‑globulin 
intravenously
195 (36.8 %) 12 (85.7 %) 0.000
Use of antibiotics 509 (96.0 %) 14 (100.0 %) 0.999
Use of glucocorticoids 129 (24.3 %) 11 (78.6 %) 0.000
Mechanical ventilation 29 (5.5 %) 5 (35.7 %) 0.001
Length of fever (days) 7 (0–62) 15.5 (6–30) 0.000
Length of hospital stay 
(days)
7 (2–74) 19.5 (8–55) 0.000
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of BO, which indicated that patients with hypoxemia kept 
significantly higher incidence of BO than those without 
hypoxemia (Fig. 1).
Discussion
BO is a severe chronic sequelain children following 
respiratory adenoviral infection (Champs et  al. 2011; 
Murtagh et  al. 2009). Due to its low incidence, the pre-
dictors of BO were still unclear. Respiratory viral infec-
tion was confirmed to be a distinct risk for BO (Khalifah 
et al. 2004). Among the entire suspected virus, adenovi-
rus was confirmed to be the major causes (Murtagh et al. 
2009). Previous studies found that mechanical ventila-
tion, >30  days of hospitalization, multifocal pneumonia 
and hypercapnia were the predictors of BO in children 
with acute bronchitis (Murtagh et  al. 2009; Colom and 
Teper 2009; Yalcin et al. 2003; Khalifah et al. 2004). Some 
studies failed to identify the predictors due to limited 
sample sizes (Yalcin et al. 2003). Above all, few prognos-
tic factors achieved worldwide acknowledgment, which 
might due to limited sample sizes and the heterogenicity 
of this disease.
In the present study, we found that hypoxemia was the 
independent predictor of BO in adenovirus infected chil-
dren, which was a novel finding. It usually preceded the 
previous reported risk factors such as hypercapnia and 
mechanical ventilation (Jouett et  al. 2015; Wilson and 
Matthay 2014), which made it more sensitive than other 
predictors. The causes and mechanism of development of 
BO was still unclear (Kim et al. 2006; Gedik et al. 2015; 
Costa et al. 2005; Mallol et al. 2011). In order to achieve 
reliable results, prognostic analysis of BO shall be based 
on simple disease background. Since adenoviral infec-
tion was identified as the major cause of BO in children 
(Murtagh et al. 2009), it is optimal to investigate the pre-
dictors for BO following respiratory adenoviral infection 
in children. Due to the low incidence of BO, multiple 
center based studies shall be the optimal choice for better 
understanding of this sequela.
In the present study, pulmonary function measure-
ments were not conducted due the ages of BO children. 
Most of them are younger than 5 years, which made the 
pulmonary function measurements unreliable due to 
their incompatibility. Meanwhile, pathological diagno-
sis was not achieved due to the risk of biopsy in symp-
tomatic young children and reluctance of their parents. 
However, the diagnosis of BO in most of the studies was 
not based on pathological diagnosis (Li et al. 2014; Gedik 
et  al. 2015; Giubergia et  al. 2015). And diagnosis based 
on CT and clinical features was acceptable to most of the 
researchers. We did not test co-infection of other virus 
and specific types of adenovirus, due to the low incidence 
of BO and sub-analysis needed multi-center based stud-
ies with larger sample sizes.
Conclusions
In summary, the present study identified hypoxemia 
as the independent predictive factor of BO in adenovi-
ral infected children, which was a novel and sensitive 
predictor.
Table 3 Logistic analysis of predictive parameters
95 % CI 95 % confidence interval
Factors Univariate analysis Multivariate analysis
p HR (95 % CI) p HR (95 % CI)
Length of hospital stay 0.000 1.086 (1.046–1.127) 0.056 1.044 (0.999–1.090)
Length of fever 0.003 1.062 (1.020–1.106) 0.997 1.000 (0.942–1.062)
Use of glucocorticoids 0.000 11.398 (3.131–41.486) 0.056 4.036 (0.964–16.907)
Mechanical ventilation 0.000 9.598 (3.022–30.480) 0.612 1.438 (0.354–5.849)
Hypoxemia 0.000 14.000 (3.839–51.050) 0.030 5.046 (1.170–21.765)
Use of γ‑globulin intravenously 0.002 10.308 (2.283–46.535) 0.474 1.935 (0.317–11.806)
Fig. 1 Incidence of BO in adenovirus infected children with or with‑
out hypoxemia. BO bronchiolitis obliterans
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